The company that owns Oxford: We will not stop Corona vaccine trials after the death of a volunteer


AstraZenka, the owner of the Oxford University Vaccine It is possible for Coronavirus, that the death of a person who is registered as a volunteer for the AstraZeneca COVID-19 vaccine trials in Brazil will not impede the vaccine trials and study.

The company clarified, in statements to TIME NOW NEWS newspaper, that the trials of the AstraZeneca COVID-19 vaccine will not be derailed, and all medical operations have been followed following the first death of a volunteer in Brazil.

This comes after the death of a man who was registered as a volunteer in the ongoing experiments of the AstraZeneca COVID-19 vaccine in Brazil yesterday, this vaccine that was developed in cooperation with the University of Oxford, and is conducting experiments over the past few months, and this is the first time that the death of a volunteer appeared.

AstraZeneca confirmed that the volunteer’s death would not impede the ongoing trials, refusing to comment on the deceased person’s condition, and the pharmaceutical company said that all required review processes were followed.


According to the newspaper, AstraZeneca said, “We cannot comment on individual cases in an ongoing Oxford vaccine trial because we strictly adhere to medical confidentiality and clinical trial regulations, but we can confirm that all required review processes have been followed. All significant medical events are carefully evaluated by the trial investigators and the Safety Oversight Committee.” These independent and regulatory authorities’ assessments did not lead to any concerns about the continuation of the ongoing study.

Trials of various COVID-19 vaccines have continued around the world in the past few months in the hope of providing a functional and appropriate vaccine to the public.


Please enter your comment!
Please enter your name here